Aspirin has been recommended by various authorities for primary and secondary prevention of cardiovascular disease (CVD). This review aims to analyse the evidence base of these recommendations to gain insight into their merits and limitations. Use of aspirin for secondary prevention has a more convincing case however in light of recent guidelines; aspirin’s role in primary prevention is also be...

BACKGROUND Cardiovascular diseases (CVD) are a leading contributor to the burden of disease in low- and middle-income countries. Guidelines for CVD prevention care in low resource settings have been developed but little information is available on strategies to implement this care. A community health insurance program might be used to improve patients' access to care. The operational research p...

OBJECTIVES We aimed to study the prevalence of cardiovascular disease (CVD) risk factors among 11,000 inhabitants in Northern Helsinki, and to identify high-risk individuals in the area and direct them to the local primary-health-care-centred CVD-risk-factor prevention programme. METHOD We conducted a computer-assisted telephone interview (CATI), a descriptive survey and primary care unit sea...

BACKGROUND Daily low-dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher-risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/St. Paul, 2010 population 2.85 million) from 1980 to 2009 were evaluated. METHODS AND RESULTS Surveys of randomly selected adults aged 25 to 74 years...

The effective prevention of cardiovascular disease (CVD) remains a global health challenge. Adopting a combined primary (prevention of the first episode of coronary heart disease or stroke) and primordial (prevention of the causal risk factors of CVD) prevention strategy is the best approach to prevent CVD. Most importantly, the primordial prevention strategy should in the first place be to pro...

In this systematic review, the authors aimed to assess the effectiveness of community programs for prevention of cardiovascular disease (CVD). They searched numerous electronic databases (CDSR, DARE, HTA, EED, and CENTRAL via the Cochrane Library, MEDLINE, MEDLINE In Process, EMBASE, CINAHL, PsycINFO, HMIC, and ASSIA) and relevant Web sites from January 1970 to mid-July 2008. Controlled studies...

   Background & Objective: Cardiovascular disease (CVD) is the main cause of morbidity and mortality in most countries. By identifying the population attributable risk (PAR) of the main risk factors of CVDs, the overall effect of various exposures on a population can be determined; the findings could be used in CVD prevention. The present study aimed to explore the PAR of some factors, includin...

Cardiovascular disease (CVD) is the leading cause of death for US women, and nearly two thirds who died suddenly of CVD had no previous symptoms.1 Therefore, it is of great importance to identify “at-risk” women early, so that effective primary prevention strategies can be instituted. A universal recommendation of prevention guidelines is that all asymptomatic women should undergo a global risk...

Source of Funding: Self Conflicts of interest: None DOI: 10.16965/ijims.2016.124 Cardiovascular disease (CVD) is a main cause of morbidity and mortality worldwide. Its prevention through a healthy lifestyle and appropriate diet is important. Omega-3 polyunsaturated fatty acids (n-3 PUFA) therapy has shown promise in both primary and secondary prevention of CVD. This commentary reviews the nutri...